2F8U image
Deposition Date 2005-12-03
Release Date 2006-11-07
Last Version Date 2024-05-01
Entry Detail
PDB ID:
2F8U
Keywords:
Title:
G-quadruplex structure formed in human Bcl-2 promoter, hybrid form
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Conformers Calculated:
20
Conformers Submitted:
10
Selection Criteria:
structures with the least restraint violations,structures with the lowest energy
Macromolecular Entities
Polymer Type:polydeoxyribonucleotide
Molecule:5'-D(*GP*GP*GP*CP*GP*CP*GP*GP*GP*AP*GP*GP*AP*AP*TP*TP*GP*GP*GP*CP*GP*GP*G)-3'
Chain IDs:A
Chain Length:23
Number of Molecules:1
Biological Source:
Ligand Molecules
Primary Citation
NMR solution structure of the major G-quadruplex structure formed in the human BCL2 promoter region.
Nucleic Acids Res. 34 5133 5144 (2006)
PMID: 16998187 DOI: 10.1093/nar/gkl610

Abstact

BCL2 protein functions as an inhibitor of cell apoptosis and has been found to be aberrantly expressed in a wide range of human diseases. A highly GC-rich region upstream of the P1 promoter plays an important role in the transcriptional regulation of BCL2. Here we report the NMR solution structure of the major intramolecular G-quadruplex formed on the G-rich strand of this region in K+ solution. This well-defined mixed parallel/antiparallel-stranded G-quadruplex structure contains three G-tetrads of mixed G-arrangements, which are connected with two lateral loops and one side loop, and four grooves of different widths. The three loops interact with the core G-tetrads in a specific way that defines and stabilizes the overall G-quadruplex structure. The loop conformations are in accord with the experimental mutation and footprinting data. The first 3-nt loop adopts a lateral loop conformation and appears to determine the overall folding of the BCL2 G-quadruplex. The third 1-nt double-chain-reversal loop defines another example of a stable parallel-stranded structural motif using the G3NG3 sequence. Significantly, the distinct major BCL2 promoter G-quadruplex structure suggests that it can be specifically involved in gene modulation and can be an attractive target for pathway-specific drug design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures